We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Judge Allows Drug Battle Over TriCor To Proceed

Law360 (June 1, 2006, 12:00 AM EDT) -- In the latest in a long-running battle between pharmaceutical companies over generic versions of the cholesterol drug TriCor, a judge has ruled that a pending antitrust case against Abbott Laboratories can proceed.

Attorneys for Abbott Laboratories and Fournier Industrie et Sante asked Judge Kent Jordan to dismiss a lawsuit alleging that they manipulated antitrust laws to keep a generic equivalent of TriCor, or Fenofibrate, off the market.

Abbott markets TriCor in the U.S. for French drug maker Fournier.

Jordan dismissed the drug companies' arguments in a...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.